VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 669 filers reported holding VANECK VECTORS ETF TR in Q1 2021. The put-call ratio across all filers is 1.04 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,032,380 | -16.5% | 38,364 | -6.5% | 0.10% | -14.4% |
| Q2 2023 | $1,235,870 | -9.1% | 41,045 | -2.4% | 0.12% | -16.9% |
| Q1 2023 | $1,360,161 | +21.2% | 42,045 | +7.3% | 0.14% | +16.4% |
| Q4 2022 | $1,122,648 | +73.8% | 39,171 | +46.2% | 0.12% | +71.8% |
| Q3 2022 | $646,000 | -18.1% | 26,789 | -7.0% | 0.07% | -13.4% |
| Q2 2022 | $789,000 | -41.3% | 28,809 | -17.7% | 0.08% | -31.7% |
| Q1 2022 | $1,343,000 | +19.5% | 35,014 | -0.2% | 0.12% | +21.2% |
| Q4 2021 | $1,124,000 | -0.3% | 35,091 | +3.6% | 0.10% | -2.0% |
| Q3 2021 | $1,127,000 | +1.3% | 33,887 | -0.9% | 0.10% | -24.6% |
| Q1 2021 | $1,112,000 | -15.9% | 34,210 | -6.8% | 0.13% | -23.0% |
| Q4 2020 | $1,323,000 | +65.4% | 36,724 | +79.7% | 0.17% | +19.2% |
| Q3 2020 | $800,000 | – | 20,438 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Harbor Financial Group, LLC | 2,418,400 | $77,461,000 | 26.62% |
| Brevan Howard Capital Management LP | 1,000,000 | $32,030,000 | 23.21% |
| Windmill Hill Asset Management Ltd | 844,600 | $27,053,000 | 19.48% |
| Memorial Sloan Kettering Cancer Center | 738,500 | $23,654,000 | 14.86% |
| New Harbor Financial Group, LLC | 1,286,391 | $41,203,000 | 14.16% |
| Eschler Asset Management LLP | 300,000 | $9,609,000 | 12.30% |
| Hollow Brook Wealth Management LLC | 712,669 | $22,827,000 | 11.71% |
| Grand Central Investment Group | 284,547 | $9,114,000 | 10.90% |
| Baymount Management LP | 500,000 | $16,015,000 | 9.54% |
| Nokomis Capital, L.L.C. | 512,628 | $16,419,000 | 6.93% |